Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Warren, Tong"'
Autor:
Lam, Sze-Mun, Sin, Jin-Chung, Warren Tong, Meng Wei, Zeng, Honghu, Li, Haixaing, Huang, Liangliang, Lin, Hua, Lim, Jun-Wei
Publikováno v:
In Chemosphere December 2023 344
Autor:
Clayton Spada, Chau Vu, Iona Raymond, Warren Tong, Chia-Lin Chuang, Christopher Walker, Kerry Loomes, David F. Woodward, Neil J. Poloso
Publikováno v:
Prostaglandins, leukotrienes, and essential fatty acids. 187
Bimatoprost is a synthetic prostamide F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::597ee0eafcc7b6c928e938504dea09ea
https://pubmed.ncbi.nlm.nih.gov/36399889
https://pubmed.ncbi.nlm.nih.gov/36399889
Autor:
C.S. Spada, Chia-Lin Chuang, David F. Woodward, Iona Raymond, Christopher S. Walker, Kerry M. Loomes, Neil J. Poloso, C. Vu, Warren Tong
Background Bimatoprost negatively regulates adipogenesis in vitro and likely participates in a negative feedback loop on anandamide-induced adipogenesis. Here, we investigate the broader metabolic effects of bimatoprost action in vivo in rats under b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a397e70f123309547408e4ca51b27ce6
https://doi.org/10.21203/rs.3.rs-24991/v1
https://doi.org/10.21203/rs.3.rs-24991/v1
Autor:
Joely Kaufman-Janette, Brian S. Biesman, Rodney J Rohrich, Shannon Humphrey, Warren Tong, Jason K. Rivers, David E. Bank, Channy Muhn, Derek K. Jones, Steven H. Dayan, Vince Bertucci
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB171
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9a31b5707b4b5cc963c8f5262a630d3
https://doi.org/10.1016/j.jaad.2021.06.698
https://doi.org/10.1016/j.jaad.2021.06.698
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Jie Shen,1 Margot L Goodkin,2 Warren Tong,2 Mayssa Attar3 1Clinical Pharmacology, 2Clinical Development, 3Clinical Pharmacology, Metabolism and Immunology, Allergan plc, Irvine, CA, USA Purpose: Fixed-combination medications can benefit patients requ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d725e4ce4c480c8d5ad08eee1d0c7490
http://europepmc.org/articles/PMC5627754
http://europepmc.org/articles/PMC5627754
Publikováno v:
Clinical Drug Investigation
Background Overactive bladder (OAB) is often associated with a number of co-morbid medical conditions, including diabetes mellitus. This may necessitate several concomitant treatments, thus creating the potential for drug–drug interactions (DDIs).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f0f06f67a71a76817d9d807cb37851
https://doi.org/10.1007/s40261-012-0049-6
https://doi.org/10.1007/s40261-012-0049-6
Autor:
Michael T, Jarratt, Terry M, Jones, Joan-En, Chang-Lin, Warren, Tong, David R, Berk, Vince, Lin, Alexandre, Kaoukhov
Publikováno v:
Journal of drugs in dermatology : JDD. 15(10)
Reducing the dosing frequency of topical acne treatments to once daily may improve adherence.Evaluate pharmacokinetics (PK), safety, and tolerability of 3 formulations of once-daily dapsone gel, 7.5% and of twice-daily dapsone gel, 5% over 28 days in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b8e8ce52a8a2522a9727badb0697f22b
https://pubmed.ncbi.nlm.nih.gov/27741344
https://pubmed.ncbi.nlm.nih.gov/27741344
Autor:
Sangot Marzuki, Mansour Alemi, Steven R. Danielson, Warren Tong, Valerio Carelli, Alice Wong, Kari Majamaa, Andrea Martinuzzi, Gino A Cortopassi, Shan Shan Zhan
Publikováno v:
Mitochondrion. 6(4)
Mutations in gene products expressed in the mitochondrion cause a nuclear transcriptional response that leads to neurological disease. To examine the extent to which the transcriptional profile was shared among 5 mitochondrial diseases (LHON, FRDA, M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f24b357083e6634a7ca762ef5163b988
https://pubmed.ncbi.nlm.nih.gov/16815102
https://pubmed.ncbi.nlm.nih.gov/16815102
Autor:
Sadayappan V. Rahavendran, Karen J. Klamerus, Paulina Selaru, Yazdi K. Pithavala, Warren Tong, Janessa Mount, Brian Hee, Nenad Sarapa, May Garrett
Publikováno v:
Investigational New Drugs
Summary Objective Axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, is metabolized primarily by cytochrome P450 (CYP) 3A with minor contributions from CYP1A2, CYP2C19, and gluc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d974be5801650258e7c832863008ee7c